RecruitingNCT06583408

The REgistry of Very Early Estrogen and AnovuLation


Sponsor

Mayo Clinic

Enrollment

100,000 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) and REVEAL Questionnaire for people with functional hypogonadotropic hypogonadism, hypothalamic amenorrhea, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAutomated Self-Administered 24-hour Dietary Assessment Tool (ASA24)

Subjects will complete the ASA food diary for 2 weekdays and 1 weekend day

OTHERREVEAL Questionnaire

Subjects will complete the REVEAL questionnaire form. This form includes questions about current and past medical history, including reproductive history, lifestyle specifics, and assessment of current health status.


Locations(2)

Mayo Clinic

Jacksonville, Florida, United States

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06583408


Related Trials